Omada Health, Inc. (OMDA)

Omada Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	260.21	169.8	122.78	89.19
Revenue Growth (YoY)	53.24%	38.29%	37.67%	-
Cost of Revenue	89.27	66.92	52.81	46.39
Gross Profit	170.94	102.88	69.97	42.79
Selling, General & Admin	142.23	110.61	102.23	88.97
Research & Development	40.68	35.92	33.74	26.17
Total Operating Expenses	182.91	146.53	135.97	115.14
Operating Income	-11.97	-43.65	-66	-72.35
Interest Income	-5.31	-0.81	-5.78	2.2
Interest Expense	2.53	4.51	4.71	-4.2
Other Non-Operating Income (Expense)	3.58	-0.22	2.58	1.83
Total Non-Operating Income (Expense)	0.81	3.48	1.51	-0.17
Pretax Income	-12.78	-47.14	-67.51	-72.52
Net Income	-12.78	-47.14	-67.51	-72.52
Net Income to Common	-12.78	-47.14	-67.51	-72.52
Shares Outstanding (Basic)	37	8	7	7
Shares Outstanding (Diluted)	37	8	7	7
Shares Change (YoY)	374.54%	8.88%	1.63%	-
EPS (Basic)	-0.35	-6.11	-9.52	-10.39
EPS (Diluted)	-0.35	-6.11	-9.52	-10.39
Free Cash Flow	16.93	-34.78	-50.15	-69.7
Free Cash Flow Per Share	0.46	-4.50	-7.07	-
Gross Margin	65.69%	60.59%	56.99%	47.98%
Operating Margin	-4.60%	-25.71%	-53.75%	-81.12%
Profit Margin	-4.91%	-27.76%	-54.98%	-81.31%
FCF Margin	6.51%	-20.48%	-40.85%	-78.15%
EBITDA	-6.48	-38.85	-61.55	-68.02
EBITDA Margin	-2.49%	-22.88%	-50.13%	-76.27%
EBIT	-11.97	-43.65	-66	-72.35
EBIT Margin	-4.60%	-25.71%	-53.75%	-81.12%

Updated Mar 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q